Hims & Hers Health, Inc. HIMS
29.42
0.14
0.48%
as of 25 Sep
- Market cap
- $6.9B
- P/E
- 0.0×
Follow HIMS
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 56.96 | 94.53 |
+8 more quarters Free account |
P/S ratio |
3.12 | 2.00 | 3.11 | 5.81 | |
P/FCF ratio |
96.77 | 59.47 | 98.76 | 95.88 | |
P/Operating CF |
(223.56) | 53.05 | 119.14 | 86.33 | |
P/B ratio |
24.79 | 10.63 | 13.50 | 22.10 | |
Price to Tangible BV |
0.00 | 0.00 | 109.86 | 101.24 | |
EV/Sales |
3.32 | 2.09 | 3.28 | 5.96 | |
EV/EBITDA |
0.00 | 118.84 | 47.35 | 83.39 | |
EV/Operating CF |
32.49 | 17.71 | 25.66 | 40.54 | |
EV/FCF |
103.09 | 62.27 | 104.10 | 98.43 | |
Quick Ratio |
0.82 | 1.46 | 1.51 | 1.40 | |
Current Ratio |
0.93 | 1.69 | 1.90 | 1.88 | |
Net Debt/EBITDA |
(7.97) | (4.08) | 13.96 | 11.41 | |
Debt/Assets |
37.62% | 42.97% | 45.14% | 43.48% | |
Debt/Equity |
4.21 | 2.18 | 1.80 | 1.67 | |
Asset Turnover |
0.94 | 1.50 | 1.64 | 1.56 | |
Operating CF/Net income |
0.42 | (0.97) | 2.98 | 9.43 | |
Capex/Depreciation |
(0.82) | (1.26) | (3.11) | (3.61) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
7.29% | 7.72% | 6.63% | 6.77% | |
Selling, General and Administrative Expense of Revenue |
56.77% | 54.54% | 50.86% | 52.23% | |
Intangible Assets out of Total Assets |
0.42 | 0.27 | 0.22 | 0.20 | |
Share Based Compensation of Revenue |
5.59% | 6.06% | 5.58% | 6.71% | |
Graham Net Nets |
(0.24) | (0.16) | (0.12) | (0.06) | |
Graham Number |
0.00 | 0.00 | 5.55 | 5.89 | |
Earnings Yield |
(1.76%) | (0.24%) | 1.76% | 1.06% | |
Free Cash Flow Yield |
1.03% | 1.68% | 1.01% | 1.04% | |
Revenue per Share |
3.25 | 2.66 | 2.75 | 2.65 | |
Operating CF per Share |
(0.16) | 0.39 | 0.27 | 0.66 | |
Capex per Share |
(0.11) | (0.13) | (0.26) | (0.29) | |
Free Cash Flow per Share |
(0.27) | 0.26 | 0.01 | 0.37 | |
Cash per Share |
3.63 | 3.29 | 2.57 | 2.78 | |
Shareholders Equity per Share |
1.40 | 1.95 | 2.40 | 2.57 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.40 | 1.95 | 2.40 | 2.57 | |
Free Cash Flow |
(61.86) | 59.51 | 1.92 | 83.46 | |
Working Capital |
(98.62) | 426.59 | 363.21 | 394.48 | |
Capital Expenditures |
(25.93) | (29.84) | (59.39) | (65.26) | |
Net Current Asset Value |
(1,920.13) | (775.51) | (846.14) | (807.06) | |
EV/EBIT |
0.00 | 0.00 | 72.90 | 114.58 | |
Capex to Sales |
0.03 | 0.05 | 0.10 | 0.11 | |
Net Profit Margin |
(11.46%) | (15.15%) | 3.33% | 2.63% | |
Price to Operating Income |
0.00 | 0.00 | 69.16 | 111.62 | |
| Other line items | |||||
Average Receivables |
189.60 | 77.05 | 17.69 | — | |
Average Payables |
303.15 | 207.89 | 117.23 | 136.93 | |
Average Inventory |
114.79 | 77.58 | 72.28 | 77.55 | |
Average Assets |
2,753.20 | 1,579.38 | 1,431.12 | 1,417.78 | |
Average Common Equity |
443.38 | 497.71 | 508.82 | 510.52 |
Columns are period end dates